Altimmune Inc (ALT) Event May 12, 2022, 00:00 UTC (61% Neutral) ALTIMMUNE, INC. (ALT) Reports Net Loss for 2022-03-31 Full text
Register to leave comments News bot Oct. 29, 2025, 8:52 a.m. 🏢 Altimmune Inc (ALT) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-05-12 📊 Period of Report: 2022-03-31 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-14.86M $-14.86M N/A +0.00% ➡️ Total Assets $218.87M $205.66M $13.21M +6.42% 📈 Total Liabilities $19.73M $20.79M $-1.06M -5.11% 📈 Stockholders' Equity $246.44M $-5.04M $251.48M +4990.59% 📈 Operating Income/Loss $-14.86M $-19.50M $4.64M +23.79% 📉 R&D Expense $11.88M $15.10M $-3.23M -21.36% 📈 Earningspersharebasic $-0.38 $-0.44 $0.06 +13.64% 📈 Earningspersharediluted $-0.38 $-0.44 $0.06 +13.64% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Altimmune Inc (ALT) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document